Webinar Date/Time: Thu, Dec 8, 2022 2:00 PM EST
How can we transform the critical practice of pharmacovigilance for the 21st Century, and leverage point-of-care technology to improve real-world safety reporting? Join Dr. Auren Weinberg, Chief Medical Officer at Veradigm and Mac Bonafede, Vice President of Research Consulting at Veradigm for a discussion about how to improve real-world safety reporting through point of care technology.
Register Free: https://www.pharmexec.com/pe_w/point_of_care
Event Overview:
A growing body of evidence exists demonstrating low rates of case reporting for adverse events (AEs) - some estimates suggest that over 95% go unreported.1 A U.S. Food and Drug Administration (FDA) report estimates that only one in ten AEs are reported.2 What limited reporting that does take place is often plagued by incomplete documentation and long follow-up times – increasing the burden on healthcare providers who already have limited time and resources. How can we transform the critical practice of pharmacovigilance for the 21st Century, and leverage point-of-care technology to improve real-world safety reporting? In this webcast, we explore whether technology can help reduce the physician burden associated with real-world safety reporting and provide actionable considerations for how to leverage technology to improve your pharmacovigilance programs.
Key Learning Objectives:
Who Should Attend:
References:
1. Trifirò G, Crisafulli S. A new era of pharmacovigilance: Future challenges and opportunities. Frontiers in Drug Safety and Regulation. 2022;2. doi:10.3389/fdsfr.2022.866898
2. World of Drug Safety Module. CDER World. FDA. 2022. https://www.accessdata.fda.gov/scripts/cderworld/index.cfm?action=drugsafety:main&unit=1&lesson=1&topic=8&page=4
Speakers
Mac Bonafede
Vice President
Real World Evidence
Veradigm
Mac is Vice President of Real World Evidence at Veradigm, where he leads a team of data scientists, statisticians, and epidemiologists in conducting and guiding real-world health economics and outcomes research studies. Mac’s team is adept at using varied real-world data sources to generate real-world evidence findings in a range of therapeutic areas. Before joining Veradigm,
Dr. Bonafede was with IBM Watson Health (previously Truven Health Analytics and Thomson Reuters Healthcare). Prior to that, he served on the faculty of the Albany College of Pharmacy, where he taught courses covering research and statistical methods, total quality management, and evidence-based medicine.
Dr. Bonafede continues to teach in the University of New Hampshire Department of Health Management and Policy’s Master’s Degree in Health Data Science. He holds a PhD in health services research and policy, and a master’s degree in public health, both from the University of Rochester. Outside of work, Mac is likely to be found working on his family’s 200-year-old farmhouse in southern New Hampshire or unsuccessfully trying his hand at small-scale agriculture and homesteading.
Dr. Weinberg
Chief Medical Officer
Veradigm
Dr. Weinberg is Chief Medical Officer at Veradigm where he focuses on Patient Safety, bringing clinical perspective to improve products, and engaging healthcare staff to understand and meet their needs.Before joining Veradigm, Dr. Weinberg created and owned a comprehensive medical practice which focused on the whole health of the patient using the Patient Centered Medical Home model. He co-founded an Independent Physicians Association and Accountable Care Organization, helped build a Direct Primary Care Network, and has served as Chief Medical Officer of a state-wide heatlh plan.
He received his Master of Business Administration degree from Fox School of Business at Temple University, received his Medical Doctor Degree from University of Rochester School of Medicine & Dentistry, and a Bachelor of Arts degree from Haverford College. He trained at the Children’s Hospital of Philadelphia where he also served as Chief Resident.
As a private pilot and passionate aviation fan, he supports aviation safety by serving as a Senior Aviation Medical Examiner in his spare time. He also enjoys watching and playing soccer, reading and learning about healthcare, and exercising alongside his wife in the Florida sunshine.
Register Free: https://www.pharmexec.com/pe_w/point_of_care
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.